Skip to main content
Home / Materials Express, Volume 12, Number 10

Open Access Sulfur hexafluoride microbubbles combined with serology distinguish benign and malignant ovarian tumors

Source: Materials Express, Volume 12, Number 10, October 2022, pp. 1264-1268(5)

Publisher: American Scientific Publishers

DOI: https://doi.org/10.1166/mex.2022.2253

To explore the value of contrast-enhanced ultrasound with Sulfur hexafluoride microbubbles, serum carbohydrate antigen 125, carcinoembryonic antigen and human epididymis protein 4 joint inspection in the differential diagnosis of ovarian tumors. A total of 56 patients with ovarian tumors were chosen as research materials from June 2018 to October 2021. Result show 24 patients of benign tumors and 32 patients of malignant tumors were confirmed by pathological diagnosis. The rise time and time to peak values of malignant tumors were lower than those of benign tumors (p<0.001). However, peak intensity, Time intensity curve -Area under Curve and serum human epididymis protein 4, carcinoembryonic antigen, carbohydrate antigen 125 levels joint inspection in malignant tumors were higher than those in benign tumors (p < 0.001). Rise time, peak intensity and time to peak in benign and malignant ovarian tumors were 0.895 (0.802–0.999, 95% CI), 0.852 (0.804–0.916, 95% CI), 0.907 (0.829–0.925, 95% CI), respectively. Area under Curve were 0.909 (0.846–1.012, 95% CI) and serum carbohydrate antigen 125 and carcinoembryonic antigen and human epididymis protein 4 for diagnosis of benign and malignant ovarian tumors were 0.865 (0.838–0.991, 95% CI), 0.816 (0.702–0.930, 95% CI), 0.903 (0.850–1.007, 95% CI). Contrast-enhanced Ultrasound unite to serum carbohydrate antigen 125 and carcinoembryonic antigen and human epididymis protein 4, the accuracy rate 92.86% (52/56) significantly higher than Contrast-enhanced Ultrasound or serum v diagnosis benign and malignant of ovarian tumor (p<0.01, 92.86% vs. 82.14%, p<0.001, 92.86% vs. 73.21%). Conclusion Contrast-enhanced Ultrasound, carbohydrate antigen 125, carcinoembryonic antigen, human epididymis protein 4 joint inspection can improve the accuracy of early ovarian cancer.

Keywords: Benign Ovarian Tumor; Contrast-Enhanced Ultrasound; Distinguishing; Malignant Ovarian Tumor

Document Type: Research Article

Affiliations: 1: Department of Ultrasound, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, 412007, Hunan, PR China 2: Department of Burn Plastic Surgery, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, 412007, Hunan, PR China 3: Department of Anorectal Section, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, 412007, Hunan, PR China 4: Department of Obsterics and Gynecology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, 412007, Hunan, PR China

Publication date: 01 October 2022

More about this publication?
  • Materials Express is a peer-reviewed multidisciplinary journal reporting emerging researches on materials science, engineering, technology and biology. Cutting-edge researches on the synthesis, characterization, properties, and applications of a very wide range of materials are covered for broad readership; from physical sciences to life sciences. In particular, the journal aims to report advanced materials with interesting electronic, magnetic, optical, mechanical and catalytic properties for industrial applications.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content

AltStyle によって変換されたページ (->オリジナル) /